These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
530 related articles for article (PubMed ID: 27050399)
1. Azole susceptibility in clinical and environmental isolates of Aspergillus fumigatus from eastern Hokkaido, Japan. Toyotome T; Fujiwara T; Kida H; Matsumoto M; Wada T; Komatsu R J Infect Chemother; 2016 Sep; 22(9):648-50. PubMed ID: 27050399 [TBL] [Abstract][Full Text] [Related]
2. First determination of azole resistance in Aspergillus fumigatus strains carrying the TR34/L98H mutations in Turkey. Özmerdiven GE; Ak S; Ener B; Ağca H; Cilo BD; Tunca B; Akalın H J Infect Chemother; 2015 Aug; 21(8):581-6. PubMed ID: 26048062 [TBL] [Abstract][Full Text] [Related]
3. Azole-resistant Aspergillus fumigatus Containing a 34-bp Tandem Repeat in cyp51A Promoter is Isolated from the Environment in Japan. Onishi K; Muhammad Sarumoh B; Hagiwara D; Watanabe A; Kamei K; Toyotome T Med Mycol J; 2017; 58(2):E67-E70. PubMed ID: 28566661 [TBL] [Abstract][Full Text] [Related]
4. Surveillance for azole resistance in clinical and environmental isolates of Aspergillus fumigatus in Australia and cyp51A homology modelling of azole-resistant isolates. Talbot JJ; Subedi S; Halliday CL; Hibbs DE; Lai F; Lopez-Ruiz FJ; Harper L; Park RF; Cuddy WS; Biswas C; Cooley L; Carter D; Sorrell TC; Barrs VR; Chen SC J Antimicrob Chemother; 2018 Sep; 73(9):2347-2351. PubMed ID: 29846581 [TBL] [Abstract][Full Text] [Related]
5. Insight into the Significance of Aspergillus fumigatus cyp51A Polymorphisms. Garcia-Rubio R; Alcazar-Fuoli L; Monteiro MC; Monzon S; Cuesta I; Pelaez T; Mellado E Antimicrob Agents Chemother; 2018 Jun; 62(6):. PubMed ID: 29632011 [TBL] [Abstract][Full Text] [Related]
6. First clinical isolation report of azole-resistant Aspergillus fumigatus with TR Toyotome T; Hagiwara D; Kida H; Ogi T; Watanabe A; Wada T; Komatsu R; Kamei K J Infect Chemother; 2017 Aug; 23(8):579-581. PubMed ID: 28109740 [TBL] [Abstract][Full Text] [Related]
7. Aspergillus fumigatus harbouring the sole Y121F mutation shows decreased susceptibility to voriconazole but maintained susceptibility to itraconazole and posaconazole. Lescar J; Meyer I; Akshita K; Srinivasaraghavan K; Verma C; Palous M; Mazier D; Datry A; Fekkar A J Antimicrob Chemother; 2014 Dec; 69(12):3244-7. PubMed ID: 25125676 [TBL] [Abstract][Full Text] [Related]
8. In Vitro Activity of ASP2397 against Aspergillus Isolates with or without Acquired Azole Resistance Mechanisms. Arendrup MC; Jensen RH; Cuenca-Estrella M Antimicrob Agents Chemother; 2016 Jan; 60(1):532-6. PubMed ID: 26552973 [TBL] [Abstract][Full Text] [Related]
9. Prevalence, mechanisms and genetic relatedness of the human pathogenic fungus Aspergillus fumigatus exhibiting resistance to medical azoles in the environment of Taiwan. Wang HC; Huang JC; Lin YH; Chen YH; Hsieh MI; Choi PC; Lo HJ; Liu WL; Hsu CS; Shih HI; Wu CJ; Chen YC Environ Microbiol; 2018 Jan; 20(1):270-280. PubMed ID: 29124846 [TBL] [Abstract][Full Text] [Related]
13. Azole antifungal resistance in Aspergillus fumigatus: 2008 and 2009. Bueid A; Howard SJ; Moore CB; Richardson MD; Harrison E; Bowyer P; Denning DW J Antimicrob Chemother; 2010 Oct; 65(10):2116-8. PubMed ID: 20729241 [TBL] [Abstract][Full Text] [Related]
14. Azole resistance among clinical isolates of Aspergillus fumigatus in Lima-Peru. Bustamante B; Illescas LR; Posadas A; Campos PE Med Mycol; 2020 Jan; 58(1):54-60. PubMed ID: 31329931 [TBL] [Abstract][Full Text] [Related]
15. The cdr1B efflux transporter is associated with non-cyp51a-mediated itraconazole resistance in Aspergillus fumigatus. Fraczek MG; Bromley M; Buied A; Moore CB; Rajendran R; Rautemaa R; Ramage G; Denning DW; Bowyer P J Antimicrob Chemother; 2013 Jul; 68(7):1486-96. PubMed ID: 23580559 [TBL] [Abstract][Full Text] [Related]
16. Isolation of azole-resistant Aspergillus fumigatus from the environment in the south-eastern USA. Hurst SF; Berkow EL; Stevenson KL; Litvintseva AP; Lockhart SR J Antimicrob Chemother; 2017 Sep; 72(9):2443-2446. PubMed ID: 28575384 [TBL] [Abstract][Full Text] [Related]
17. [The Current Status of Drug-resistant Aspergillus]. Tashiro M; Izumikawa K Med Mycol J; 2016; 57(3):J103-12. PubMed ID: 27581778 [TBL] [Abstract][Full Text] [Related]
18. High detection rate of azole-resistant Aspergillus fumigatus after treatment with azole antifungal drugs among patients with chronic pulmonary aspergillosis in a single hospital setting with low azole resistance. Takeda K; Suzuki J; Watanabe A; Arai T; Koiwa T; Shinfuku K; Narumoto O; Kawashima M; Fukami T; Tamura A; Nagai H; Matsui H; Kamei K Med Mycol; 2021 Apr; 59(4):327-334. PubMed ID: 32642756 [TBL] [Abstract][Full Text] [Related]
19. Pesticide behavior in paddy fields and development of azole-resistant Aspergillus fumigatus: Should we be concerned? Vaezi A; Fakhim H; Javidnia J; Khodavaisy S; Abtahian Z; Vojoodi M; Nourbakhsh F; Badali H J Mycol Med; 2018 Mar; 28(1):59-64. PubMed ID: 29496370 [TBL] [Abstract][Full Text] [Related]
20. [Phenotypic and Genotypic Evaluation of Azole Resistance in Aspergillus fumigatus Isolates from Clinical and Environmental Specimens]. Doğan Ö; Gülmez D; Arıkan Akdağlı S Mikrobiyol Bul; 2020 Apr; 54(2):291-305. PubMed ID: 32723284 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]